Human FOXO1/FKH1/FKHR ORF/cDNA clone-Adenovirus plasmid (NM_002015)
Cat. No.: pGMAD000525
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FOXO1/FKH1/FKHR adenoviral expression plasmid for FOXO1 adenovirus packaging, FOXO1 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
FOXO1/FKH1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAD000525 |
| Gene Name | FOXO1 |
| Accession Number | NM_002015 |
| Gene ID | 2308 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 1968 bp |
| Gene Alias | FKH1,FKHR,FOXO1A |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCCGAGGCGCCTCAGGTGGTGGAGATCGACCCGGACTTCGAGCCGCTGCCCCGGCCGCGCTCGTGCACCTGGCCGCTGCCCAGGCCGGAGTTTAGCCAGTCCAACTCGGCCACCTCCAGCCCGGCGCCGTCGGGCAGCGCGGCTGCCAACCCCGACGCCGCGGCGGGCCTGCCCTCGGCCTCGGCTGCCGCTGTCAGCGCCGACTTCATGAGCAACCTGAGCTTGCTGGAGGAGAGCGAGGACTTCCCGCAGGCGCCCGGCTCCGTGGCGGCGGCGGTGGCGGCGGCGGCCGCCGCGGCCGCCACCGGGGGGCTGTGCGGGGACTTCCAGGGCCCGGAGGCGGGCTGCCTGCACCCAGCGCCACCGCAGCCCCCGCCGCCCGGGCCGCTGTCGCAGCACCCGCCGGTGCCCCCCGCCGCCGCTGGGCCGCTCGCGGGGCAGCCGCGCAAGAGCAGCTCGTCCCGCCGCAACGCGTGGGGCAACCTGTCCTACGCCGACCTCATCACCAAGGCCATCGAGAGCTCGGCGGAGAAGCGGCTCACGCTGTCGCAGATCTACGAGTGGATGGTCAAGAGCGTGCCCTACTTCAAGGATAAGGGTGACAGCAACAGCTCGGCGGGCTGGAAGAATTCAATTCGTCATAATCTGTCCCTACACAGCAAGTTCATTCGTGTGCAGAATGAAGGAACTGGAAAAAGTTCTTGGTGGATGCTCAATCCAGAGGGTGGCAAGAGCGGGAAATCTCCTAGGAGAAGAGCTGCATCCATGGACAACAACAGTAAATTTGCTAAGAGCCGAAGCCGAGCTGCCAAGAAGAAAGCATCTCTCCAGTCTGGCCAGGAGGGTGCTGGGGACAGCCCTGGATCACAGTTTTCCAAATGGCCTGCAAGCCCTGGCTCTCACAGCAATGATGACTTTGATAACTGGAGTACATTTCGCCCTCGAACTAGCTCAAATGCTAGTACTATTAGTGGGAGACTCTCACCCATTATGACCGAACAGGATGATCTTGGAGAAGGGGATGTGCATTCTATGGTGTACCCGCCATCTGCCGCAAAGATGGCCTCTACTTTACCCAGTCTGTCTGAGATAAGCAATCCCGAAAACATGGAAAATCTTTTGGATAATCTCAACCTTCTCTCATCACCAACATCATTAACTGTTTCGACCCAGTCCTCACCTGGCACCATGATGCAGCAGACGCCGTGCTACTCGTTTGCGCCACCAAACACCAGTTTGAATTCACCCAGCCCAAACTACCAAAAATATACATATGGCCAATCCAGCATGAGCCCTTTGCCCCAGATGCCTATACAAACACTTCAGGACAATAAGTCGAGTTATGGAGGTATGAGTCAGTATAACTGTGCGCCTGGACTCTTGAAGGAGTTGCTGACTTCTGACTCTCCTCCCCATAATGACATTATGACACCAGTTGATCCTGGGGTAGCCCAGCCCAACAGCCGGGTTCTGGGCCAGAACGTCATGATGGGCCCTAATTCGGTCATGTCAACCTATGGCAGCCAGGCATCTCATAACAAAATGATGAATCCCAGCTCCCATACCCACCCTGGACATGCTCAGCAGACATCTGCAGTTAACGGGCGTCCCCTGCCCCACACGGTAAGCACCATGCCCCACACCTCGGGTATGAACCGCCTGACCCAAGTGAAGACACCTGTACAAGTGCCTCTGCCCCACCCCATGCAGATGAGTGCCCTGGGGGGCTACTCCTCCGTGAGCAGCTGCAATGGCTATGGCAGAATGGGCCTTCTCCACCAGGAGAAGCTCCCAAGTGACTTGGATGGCATGTTCATTGAGCGCTTAGACTGTGACATGGAATCCATCATTCGGAATGACCTCATGGATGGAGATACATTGGATTTTAACTTTGACAATGTGTTGCCCAACCAAAGCTTCCCACACAGTGTCAAGACAACGACACATAGCTGGGTGTCAGGCTGA |
| ORF Protein Sequence | MAEAPQVVEIDPDFEPLPRPRSCTWPLPRPEFSQSNSATSSPAPSGSAAANPDAAAGLPSASAAAVSADFMSNLSLLEESEDFPQAPGSVAAAVAAAAAAAATGGLCGDFQGPEAGCLHPAPPQPPPPGPLSQHPPVPPAAAGPLAGQPRKSSSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKSRSRAAKKKASLQSGQEGAGDSPGSQFSKWPASPGSHSNDDFDNWSTFRPRTSSNASTISGRLSPIMTEQDDLGEGDVHSMVYPPSAAKMASTLPSLSEISNPENMENLLDNLNLLSSPTSLTVSTQSSPGTMMQQTPCYSFAPPNTSLNSPSPNYQKYTYGQSSMSPLPQMPIQTLQDNKSSYGGMSQYNCAPGLLKELLTSDSPPHNDIMTPVDPGVAQPNSRVLGQNVMMGPNSVMSTYGSQASHNKMMNPSSHTHPGHAQQTSAVNGRPLPHTVSTMPHTSGMNRLTQVKTPVQVPLPHPMQMSALGGYSSVSSCNGYGRMGLLHQEKLPSDLDGMFIERLDCDMESIIRNDLMDGDTLDFNFDNVLPNQSFPHSVKTTTHSWVSG |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T72850-Ab | Anti-FOXO1 monoclonal antibody |
| Target Antigen | GM-Tg-g-T72850-Ag | FOXO1 protein |
| ORF Viral Vector | pGMLV000310 | Human FOXO1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV001668 | Human FOXO1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV002023 | Human FOXO1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV002427 | Human FOXO1 Lentivirus plasmid |
| ORF Viral Vector | pGMAD000137 | Human FOXO1 Adenovirus plasmid |
| ORF Viral Vector | pGMAD000525 | Human FOXO1 Adenovirus plasmid |
| ORF Viral Vector | pGMAD000764 | Human FOXO1 Adenovirus plasmid |
| ORF Viral Vector | pGMPC000687 | Human FOXO1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLV000310 | Human FOXO1 Lentivirus particle |
| ORF Viral Vector | vGMLV001668 | Human FOXO1 Lentivirus particle |
| ORF Viral Vector | vGMLV002023 | Human FOXO1 Lentivirus particle |
| ORF Viral Vector | vGMLV002427 | Human FOXO1 Lentivirus particle |
| ORF Viral Vector | vGMAD000137 | Human FOXO1 Adenovirus particle |
| ORF Viral Vector | vGMAD000525 | Human FOXO1 Adenovirus particle |
| ORF Viral Vector | vGMAD000764 | Human FOXO1 Adenovirus particle |
Target information
| Target ID | GM-T72850 |
| Target Name | FOXO1 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
2308 |
| Gene ID |
100050481 (Equus caballus), 101096628 (Felis catus), 2308 (Homo sapiens), 477295 (Canis lupus familiaris) 506618 (Bos taurus), 56458 (Mus musculus), 700030 (Macaca mulatta), 84482 (Rattus norvegicus) |
| Gene Symbols & Synonyms | FOXO1,Foxo1,FKH1,FKHR,FOXO1A,Afxh,Fkhr1,Foxo1a,Fkhr |
| Target Alternative Names | Afxh,FKH1,FKHR,FOXO1,FOXO1A,Fkhr,Fkhr1,Forkhead box protein O1,Forkhead box protein O1A,Forkhead in rhabdomyosarcoma,Foxo1,Foxo1a |
| Uniprot Accession |
E1BPQ1,G3V7R4,Q12778,Q9R1E0
Additional SwissProt Accessions: Q12778,E1BPQ1,Q9R1E0,G3V7R4 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | FoxO signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Cellular senescence, Thyroid hormone signaling pathway, Insulin resistance, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Human papillomavirus infection, Pathways in cancer, Prostate cancer |
| Gene Ensembl | ENSECAG00000002212, ENSG00000150907, ENSCAFG00845024108, ENSBTAG00000044105, ENSMUSG00000044167, ENSMMUG00000030780 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


